Report cover image

Europe Lung Cancer Diagnostics Market - Industry Trends and Forecast to 2030

Publisher Data Bridge Market Research
Published Nov 01, 2022
Length 259 Pages
SKU # DAABD17583254

Description

Europe Lung Cancer Diagnostics Market - Industry Trends and Forecast to 2030

The Europe lung cancer diagnostics market is projected to register a substantial CAGR of 13.3% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030

Market Segmentation

Europe Lung Cancer Diagnostics Market, By Product Type (Instruments, Consumables & Accessories), Test Type (Biomarkers Test, Imaging Test, Biopsy, Blood Test, and Others), Cancer Type (Non-Small Cell Lung Cancer, Small Cell Lung Cancer), End User (Hospital, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, and Others), Distribution Channel (Direct Tender, Retail Sales), Country (Germany, France, U.K, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe) Industry Trends and Forecast to 2030
Some of the major factors contributing to the growth of the Europe lung cancer diagnostics market are:
• Rise in market players and the availability of advanced services
• Increase in awareness about the lung cancer diagnostics
Market Players

Some of the major players operating in the Europe lung cancer diagnostics market are:

• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Abbott
• Quest Diagnostics Incorporated
• Bio-Rad Laboratories, Inc.
• Biocartis
• Danaher
• DiaSorin S.p.A.
• Exact Sciences UK, Ltd. (a subsidiary of Exact Science Corporation)
• Inivata Ltd.
• Myriad Genetics, Inc.
• NeoGenomics Laboratories
• PerkinElmer Inc.
• Vela Diagnostics
• QIAGEN
• Siemens Healthcare GmbH
• Veracyte, Inc.

Table of Contents

259 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Europe Lung Cancer Diagnostics Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modelling
2.7 Product Type Lifeline Curve
2.8 Primary Interviews With Key Opinion Leaders
2.9 Dbmr Market Position Grid
2.10 Market Testing Type Coverage Grid
2.11 Vendor Share Analysis
2.12 Secondary Sources
2.13 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Porter’s Five Forces
4.2 Pestel Analysis
4.3 Industry Insights
5 Epidermiology
6 Regulations
7 Market Overview
7.1 Drivers
7.1.1 Unmet Need For Non-invasive, Accurate, And Reliable Diagnostic Tests For Earlier Cancer Detection
7.1.2 Increasing Early Diagnosis Of Lungs Cancer
7.1.3 Increasing Cases Of Lung Cancer
7.1.4 Rise In Product Approvals
7.2 Restraints
7.2.1 Poor & Late Diagnosis Of Lung Cancer
7.2.2 High False-positives And Poor Sensitivity
7.3 Opportunities
7.3.1 Rise In Healthcare Expenditure For Cancer Diagnosis And Treatment
7.3.2 Government Initiatives Toward Cancer Diagnostics
7.3.3 Rising Awareness Of Lung Cancer
7.4 Challenges
7.4.1 Stringent Regulatory Framework For The Approval And Commercialization Of Cancer Diagnostic Products
7.4.2 Increased Cost, Safety, And Convenience Issues
7.4.3 Lack Of Skilled And Certified Professionals
8 Europe Lung Cancer Diagnostics Market, By Product Type
8.1 Overview
8.2 Instruments
8.2.1 Imaging Instruments
8.2.1.1 Ct Systems
8.2.1.2 Ultrasound Systems
8.2.1.3 Mri Systems
8.2.1.4 Others
8.2.2 Biopsy Instruments
8.2.2.1 Needle Biopsy
8.2.2.2 Endoscopic Biopsy
8.2.2.3 Core Biopsy
8.2.2.4 Others
8.2.3 Pathology-based Instruments
8.2.3.1 Slide Staining Systems
8.2.3.2 Tissue Processing Systems
8.2.3.3 Cell Processors
8.2.3.4 Pcr Instruments
8.2.3.5 Others Pathology-based Instruments
8.3 Consumables And Accessories
8.3.1 Kits
8.3.1.1 Dna Polymerase Kits
8.3.1.2 Nucleic Acid Isolation Kits
8.3.1.3 Pcr Kits
8.3.1.4 Others
8.3.2 Reagents
8.3.2.1 Assays
8.3.2.2 Buffers
8.3.2.3 Primers
8.3.2.4 Others
8.3.3 Probes
8.3.4 Other Consumables
9 Europe Lung Cancer Diagnostics Market, By Test Type
9.1 Overview
9.2 Imaging Test
9.2.1 Computed Tomography (Ct) Scan
9.2.2 Positron Emission Tomography (Pet) Scan
9.2.3 Chest X-ray
9.2.4 Bone Scan
9.2.5 Mri
9.2.6 Others
9.3 Biomarkers Test
9.3.1 Egfr Mutation Test
9.3.2 Kras Mutation Test
9.3.3 Alk Test
9.3.4 Her2 Test
9.3.5 Others
9.4 Biopsy
9.4.1 Needle Biopsy
9.4.2 Bronchoscopy Biopsy
9.4.3 Core Biopsy
9.4.4 Others
9.5 Blood Test
9.5.1 Complete Blood Count (Cbc)
9.5.2 Blood Chemistry Tests
9.5.3 Others
9.6 Others
10 Europe Lung Cancer Diagnostics Market, By Cancer Type
10.1 Overview
10.2 Non-small Cell Lung Cancer
10.3 Small Cell Lung Cancer
11 Europe Lung Cancer Diagnostics Market, By End User
11.1 Overview
11.2 Hospital
11.3 Associated Labs
11.4 Independent Diagnostic Laboratories
11.5 Diagnostic Imaging Centers
11.6 Cancer Research Institutes
11.7 Others
12 Europe Lung Cancer Diagnostics Market, By Distribution Channel
12.1 Overview
12.2 Direct Tender
12.3 Retail Sales
13 Europe Lung Cancer Diagnostics Market, By Region
13.1 Europe
13.1.1 Germany
13.1.2 U.K.
13.1.3 France
13.1.4 Italy
13.1.5 Spain
13.1.6 Russia
13.1.7 Netherlands
13.1.8 Switzerland
13.1.9 Turkey
13.1.10 Belgium
13.1.11 Poland
13.1.12 Denmark
13.1.13 Sweden
13.1.14 Norway
13.1.15 Finland
13.1.16 Rest Of Europe
14 Europe Lung Cancer Diagnostics Market, Company Landscape
14.1 Company Share Analysis: Europe
15 Swot Analysis
16 Company Profile
16.1 F. Hoffmann-la Roche Ltd. (2022)
16.1.1 Company Snapshot
16.1.2 Revenue Analysis
16.1.3 Company Share Analysis
16.1.4 Product Portfolio
16.1.5 Recent Developments
16.2 Thermo Fisher Scientific Inc. (2022)
16.2.1 Company Snapshot
16.2.2 Revenue Analysis
16.2.3 Company Share Analysis
16.2.4 Product Portfolio
16.2.5 Recent Developments
16.3 Abbott (2022)
16.3.1 Company Snapshot
16.3.2 Revenue Analysis
16.3.3 Company Share Analysis
16.3.4 Product Portfolio
16.3.5 Recent Developments
16.4 Quest Diagnostics Incorporated (2022)
16.4.1 Company Snapshot
16.4.2 Revenue Analysis
16.4.3 Company Share Analysis
16.4.4 Product Portfolio
16.4.5 Recent Developments
16.5 Biodesix (2022)
16.5.1 Company Profile
16.5.2 Revenue Analysis
16.5.3 Company Share Analysis
16.5.4 Product Portfolio
16.5.5 Recent Developments
16.6 Amoy Diagnostics Co., Ltd. (2022)
16.6.1 Company Snapshot
16.6.2 Product Portfolio
16.6.3 Recent Developments
16.7 Bio-rad Laboratories, Inc. (2022)
16.7.1 Company Snapshot
16.7.2 Revenue Analysis
16.7.3 Product Portfolio
16.7.4 Recent Developments
16.8 Biocartis (2022)
16.8.1 Company Snapshot
16.8.2 Revenue Analysis
16.8.3 Product Portfolio
16.8.4 Recent Developments
16.9 Boditech Med Inc.
16.9.1 Company Profile
16.9.2 Product Portfolio
16.9.3 Recent Developments
16.10 Danaher (2022)
16.10.1 Company Snapshot
16.10.2 Revenue Analysis
16.10.3 Product Portfolio
16.10.4 Recent Developments
16.11 Diasorin S.P.A. (2022)
16.11.1 Company Snapshot
16.11.2 Revenue Analysis
16.11.3 Product Portfolio
16.11.4 Recent Developments
16.12 Exact Sciences Uk, Ltd. (Subsidiary Of Exact Science Corporation) (2022)
16.12.1 Company Snapshot
16.12.2 Revenue Analysis
16.12.3 Product Portfolio
16.12.4 Recent Developments
16.13 20/20 Gene Systems
16.13.1 Company Profile
16.13.2 Product Portfolio
16.13.3 Recent Developments
16.14 Guardant Health Inc.
16.14.1 Company Profile
16.14.2 Product Portfolio
16.14.3 Recent Developments
16.15 Inivata Ltd.
16.15.1 Company Profile
16.15.2 Product Portfolio
16.15.3 Recent Developments
16.16 Lalpathlabs.Com (2022)
16.16.1 Company Snapshot
16.16.2 Revenue Analysis
16.16.3 Product Portfolio
16.16.4 Recent Developments
16.17 Lunglife Ai, Inc. (2022)
16.17.1 Company Snapshot
16.17.2 Product Portfolio
16.17.3 Recent Developments
16.18 Medgenome
16.18.1 Company Snapshot
16.18.2 Product Portfolio
16.18.3 Recent Developments
16.19 Myriad Genetics, Inc.
16.19.1 Company Snapshot
16.19.2 Product Portfolio
16.19.3 Recent Developments
16.20 Neogenomics Laboratories (2022)
16.20.1 Company Snapshot
16.20.2 Revenue Analysis
16.20.3 Product Portfolio
16.20.4 Recent Developments
16.21 Nanostring (2022)
16.21.1 Company Snapshot
16.21.2 Revenue Analysis
16.21.3 Product Portfolio
16.21.4 Recent Developments
16.22 Nanoentek
16.22.1 Company Profile
16.22.2 Product Portfolio
16.22.3 Recent Developments
16.23 Oncocyte Corporation
16.23.1 Company Profile
16.23.2 Service Portfolio
16.23.3 Recent Developments
16.24 Perkinelmer Inc
16.24.1 Company Profile
16.24.2 Revenue Analysis
16.24.3 Product Portfolio 245
List Of Tables
Table 1 Different Types Of Cancer Screening Tests For Different Types Of Cancers
Table 2 Lung Cancer Rates
Table 3 Approved Diagnostics Of Lungs Cancer
Table 4 Europe Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 5 Europe Instruments In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 6 Europe Imaging Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 7 Europe Biopsy Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 8 Europe Pathology-based Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 9 Europe Consumables & Accessories In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 10 Europe Consumables And Accessories In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 11 Europe Kits In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 12 Europe Reagents In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 13 Europe Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 14 Europe Imaging Test In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 15 Europe Imaging Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 16 Europe Biomarkers Test In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 17 Europe Biomarkers Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 18 Europe Biopsy In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 19 Europe Biopsy In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 20 Europe Blood Test In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 21 Europe Blood Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 22 Europe Others In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 23 Europe Lung Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
Table 24 Europe Non-small Cell Lung Cancer In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 25 Europe Small Cell Lung Cancer In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 26 Europe Lung Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 27 Europe Hospital In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 28 Europe Associated Labs In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 29 Europe Independent Diagnostic Laboratories In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 30 Europe Diagnostic Imaging Centers In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 31 Europe Cancer Research Institutes In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 32 Europe Others In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 33 Europe Lung Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 34 Europe Direct Tender In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 35 Europe Retail Sales In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 36 Europe Lung Cancer Diagnostics Market, By Country, 2021-2030 (Usd Million)
Table 37 Europe Lung Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 38 Europe Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 39 Europe Pathology-based Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 40 Europe Imaging Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 41 Europe Biopsy Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 42 Europe Consumables And Accessories In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 43 Europe Kits In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 44 Europe Reagents In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 45 Europe Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 46 Europe Biomarkers Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 47 Europe Imaging Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 48 Europe Biopsy In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 49 Europe Blood Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 50 Europe Lung Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
Table 51 Europe Lung Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 52 Europe Lung Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 53 Germany Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 54 Germany Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 55 Germany Pathology-based Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 56 Germany Imaging Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 57 Germany Biopsy Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 58 Germany Consumables And Accessories In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 59 Germany Kits In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 60 Germany Reagents In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 61 Germany Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 62 Germany Biomarkers Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 63 Germany Imaging Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 64 Germany Biopsy In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 65 Germany Blood Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 66 Germany Lung Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
Table 67 Germany Lung Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 68 Germany Lung Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 69 U.K. Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 70 U.K. Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 71 U.K. Pathology-based Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 72 U.K. Imaging Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 73 U.K. Biopsy Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 74 U.K. Consumables And Accessories In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 75 U.K. Kits In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 76 U.K. Reagents In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 77 U.K. Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 78 U.K. Biomarkers Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 79 U.K. Imaging Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 80 U.K. Biopsy In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 81 U.K. Blood Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 82 U.K. Lung Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
Table 83 U.K. Lung Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 84 U.K. Lung Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 85 France Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 86 France Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 87 France Pathology-based Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 88 France. Imaging Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 89 France Biopsy Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 90 France Consumables And Accessories In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 91 France Kits In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 92 France Reagents In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 93 France Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 94 France Biomarkers Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 95 France Imaging Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 96 France Biopsy In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 97 France Blood Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 98 France Lung Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
Table 99 France Lung Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 100 France Lung Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 101 Italy Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 102 Italy Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 103 Italy Pathology-based Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 104 Italy Imaging Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 105 Italy Biopsy Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 106 Italy Consumables And Accessories In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 107 Italy Kits In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 108 Italy Reagents In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 109 Italy Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 110 Italy Biomarkers Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 111 Italy Imaging Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 112 Italy Biopsy In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 113 Italy Blood Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 114 Italy Lung Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
Table 115 Italy Lung Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 116 Italy Lung Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 117 Spain Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 118 Spain Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 119 Spain Pathology-based Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 120 Spain Imaging Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 121 Spain Biopsy Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 122 Spain Consumables And Accessories In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 123 Spain Kits In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 124 Spain Reagents In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 125 Spain Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 126 Spain Biomarkers Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 127 Spain Imaging Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 128 Spain Biopsy In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 129 Spain Blood Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 130 Spain Lung Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
Table 131 Spain Lung Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 132 Spain Lung Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 133 Russia Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 134 Russia Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 135 Russia Pathology-based Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 136 Russia Imaging Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 137 Russia Biopsy Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 138 Russia Consumables And Accessories In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million) 152
List Of Figures
Figure 1 Europe Lung Cancer Diagnostics Market: Segmentation
Figure 2 Europe Lung Cancer Diagnostics Market: Data Triangulation
Figure 3 Europe Lungs Cancer Diagnostics Market: Droc Analysis
Figure 4 Europe Lung Cancer Diagnostics Market: Europe Vs Regional Market Analysis
Figure 5 Europe Lung Cancer Diagnostic Market: Company Research Analysis
Figure 6 Europe Lung Cancer Diagnostics Market: Interview Demographics
Figure 7 Europe Lung Cancer Diagnostics Market: Dbmr Market Position Grid
Figure 8 Europe Lung Cancer Diagnostics Market: Market End User Coverage Grid
Figure 9 Europe Lung Cancer Diagnostics Market: Vendor Share Analysis
Figure 10 Europe Lung Cancer Diagnostics Market: Segmentation
Figure 11 The Increase In The Awareness About Lung Cancer Is Expected To Drive The Europe Lung Cancer Diagnostics Market In The Forecast Period
Figure 12 Instruments Segment Is Expected To Account For The Largest Share Of The Europe Lung Cancer Diagnostics Market In 2023 & 2030
Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The Europe Lung Cancer Diagnostics Market
Figure 14 The Europe Mortality Rate Due To Cancer
Figure 15 The Data Given Below Shows The Increasing Europe Cancer Rate In 2020
Figure 16 Barriers To Early Cancer Diagnosis And Treatment
Figure 17 Europe Lung Cancer Diagnostics Market: By Product Type, 2022
Figure 18 Europe Lung Cancer Diagnostics Market: By Product Type, 2023-2030 (Usd Million)
Figure 19 Europe Lung Cancer Diagnostics Market: By Product Type, Cagr (2023-2030)
Figure 20 Europe Lung Cancer Diagnostics Market: By Product Type, Lifeline Curve
Figure 21 Europe Lung Cancer Diagnostics Market: By Test Type, 2022
Figure 22 Europe Lung Cancer Diagnostics Market: By Test Type, 2023-2030 (Usd Million)
Figure 23 Europe Lung Cancer Diagnostics Market: By Test Type, Cagr (2023-2030)
Figure 24 Europe Lung Cancer Diagnostics Market: By Test Type, Lifeline Curve
Figure 25 Europe Lung Cancer Diagnostics Market: By Cancer Type, 2022
Figure 26 Europe Lung Cancer Diagnostics Market: By Cancer Type, 2023-2030 (Usd Million)
Figure 27 Europe Lung Cancer Diagnostics Market: By Cancer Type, Cagr (2023-2030)
Figure 28 Europe Lung Cancer Diagnostics Market: By Cancer Type, Lifeline Curve
Figure 29 Europe Lung Cancer Diagnostics Market: By End User, 2022
Figure 30 Europe Lung Cancer Diagnostics Market: By End User, 2023-2030 (Usd Million)
Figure 31 Europe Lung Cancer Diagnostics Market: By End User, Cagr (2023-2030)
Figure 32 Europe Lung Cancer Diagnostics Market: By End User, Lifeline Curve
Figure 33 Europe Lung Cancer Diagnostics Market: By Distribution Channel, 2022
Figure 34 Europe Lung Cancer Diagnostics Market: By Distribution Channel, 2023-2030 (Usd Million)
Figure 35 Europe Lung Cancer Diagnostics Market: By Distribution Channel, Cagr (2023-2030)
Figure 36 Europe Lung Cancer Diagnostics Market: By Distribution Channel, Lifeline Curve
Figure 37 Europe Lung Cancer Diagnostics Market: Snapshot (2022)
Figure 38 Europe Lung Cancer Diagnostics Market: By Country (2022)
Figure 39 Europe Lung Cancer Diagnostics Market: By Country (2023 & 2030)
Figure 40 Europe Lung Cancer Diagnostics Market: By Country (2022 & 2030)
Figure 41 Europe Lung Cancer Diagnostics Market: By Product Type (2023-2030)
Figure 42 Europe Lung Cancer Diagnostics Market: Company Share 2022 (%) 202

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us